Non-Sterile Compounding 2018 Update - Part 1: Overview

This activity has been updated and renewed with a new ACPE number for participants to complete beginning July 2, 2018. Compounding is an integral part of pharmacy practice and is essential to the provision of healthcare. In response to numerous tragic patient outcomes, a result of the lack of attention to the main principles of USP 795, the Massachusetts Board of Registration in Pharmacy has implemented new credit requirements for those pharmacists engaging in or overseeing complex non-steril...
MCPHS University

Air (re)freshener: an update in asthma therapy

The role of the pharmacist is expanding as the field of asthma therapy management evolves. Massachusetts is among the greatest of states effected by ineffective asthma disease state control, therefore contributing to quality of life limitations, as well as financial expenditures. Inhaler therapy is currently the mainstay of asthma management, however biologic therapy is quickly making a greater presence in treatment options. Additionally, evidence suggests the need for heightened education reg...
MCPHS University

Sterile Compounding: Cleaning/Disinfection of Controlled Environments - 2018 Update

This activity has been updated and renewed with a new ACPE number for participants to complete beginning July 2, 2018. The importance of proper cleaning and disinfection of controlled environments is critical for pharmacy compounding to prevent possible contamination of CSPs. The current practices are outlined in the USP but many pharmacists have difficulty interpreting this part of the chapter. The information in this session will improve the pharmacist's knowledge and understanding of ...
MCPHS University

Parenteral Nutrition in the Critically Ill: Appropriate Administration of Intravenous Lipid Emulsions

In this complimentary continuing education activity, expert faculty formulate processes to ensure lipid emulsions adhere to evidence and guidelines, as well as devise treatment plans inclusive of parenteral nutrition (PN) for critically ill patients. This presentation was originally featured at the Society of Critical Care Medicine's 2018 Critical Care Congress. The activity agenda is as follows: 1) Evaluating Optimal Route of Nutrient Delivery, Amount of Calories, and Macronutrients for C...
Academy for Continued Healthcare Learning/Society of Critical Care Medicine

Advancing Strategies for Promoting Equality in Care: Treating Lupus

Diagnosis, Pathophysiology, and Emerging Therapeutic Targets in SLE - - Faculty discuss their perspectives on SLE diagnosis and potential therapeutic targets in the context of SLE pathophysiology, with a focus on women of color. Current Best Practices and Emerging Therapeutic Strategies in SLE Management Faculty discuss optimal management of patients with SLE and provide expert perspectives on emerging investigational agents.
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC

Breast Cancer

With breast cancer so often in the news, it is easy to forget that the diagnosis is an emotional and life-changing event for an individual patient. In the United States (US), an estimated 231,840 women and 2,350 men1 were diagnosed with invasive breast cancer in 2015. One in every 8 women in the US will be diagnosed with breast cancer during her lifetime. In contrast, a man’s lifetime risk is about 1 in 1000. Following skin cancer, breast cancer is the most commonly diagnosed cancer among wo...
The Rx Consultant

New Drugs Approved in 2015

In 2015, the FDA’s Center for Drug Evaluation and Research (CDER) approved 45 new molecular entities – the highest annual number of new drugs to be approved in the past decade (up from 41 in 2014). The new approvals include 16 first-in-class drugs spanning 14 different medical conditions. Many of the new drugs were approved under one or more of the FDA’s 4 expedited pathways (fast track, breakthrough, priority review, and accelerated approval). Nearly half are for the treatment of rare d...
The Rx Consultant

Glaucoma Management

The American Optometric Association (AOA) Guidelines classify glaucoma as a group of eye disorders that lead to damage of the optic nerve with a defect in the retinal nerve fiber layer resulting in visual field loss. Glaucoma is a chronic, progressive disorder and if not diagnosed early and treated appropriately, it can lead to an irreversible decline in eyesight. Glaucoma is a leading cause of blindness in the US. The most common type of glaucoma, open-angle glaucoma, affects approximately...
The Rx Consultant

Dementia: Managing Neuropsychiatric Symptoms

Although cognitive disturbances such as memory and language impairment are the most recognized symptoms of dementia, the neuropsychiatric symptoms of dementia (NPSD) are often more concerning and can cause considerable disability and caregiver distress. The total annual cost of treatment for a patient with Alzheimer's disease (AD) who is living at home is estimated at $14,500. The direct management of behavioral and psychological symptoms accounts for 30% of this total. The last drug approval ...
The Rx Consultant

Diabetes Update: The New Concentrated Insulin Products

In the US, approximately 22 million adults are living with diabetes; of these, 90–95% are classified as having type 2 diabetes (T2DM), a progressive disease in which beta cell function declines based on the duration of the disease and level of glycemic control. The American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) both recognize that achieving and maintaining the patient’s glycemic goals are essential for the prevention, or delay in progre...
The Rx Consultant

Update on Medication Errors and Adverse Drug Events-Florida Board-Approved Edition

Interest in medication errors was heightened by publication of the Institute of Medicine (IOM) report “To Err is Human,” which revealed the burden of medical errors and the impact on patients in the US. Following publication of the report in 2000, health care organizations bolstered efforts to reduce medical errors and the illness and death that result. Despite these efforts, a recent analysis based on studies conducted since the IOM’s report highlighted medical errors (including medicat...
The Rx Consultant

Hepatitis C Treatment: Gone Viral

Hepatitis C virus (HCV) remains a major public health concern. HCV, the most common blood borne infection in the US, is estimated to affect over 4 million Americans (about 1-2% of the population). Worldwide, over 170 million people are infected. Most Americans with HCV infection acquired it in the 1970s and 1980s, before the virus was identified. Although the rate of new infections declined between 1989-2011, there has been a recent increase in new infections since 2013. Unfortunately, there i...
The Rx Consultant

Inflammatory Bowel Disease: A Focus On Biologics

The 2 main types of inflammatory bowel disease (IBD), Crohn’s disease (CD) and ulcerative colitis (UC), affect approximately 1.17 million people in the United States. The estimated prevalence of CD in North America is 26-199 cases per 100,000 people; for UC, it is 37-246 cases per 100,000 people. During the past 25 years, the rates of newly diagnosed UC and CD cases have increased. Reasons for the increase may include wider exposure to environmental risk factors, greater awareness of IBD...
The Rx Consultant

Medical Marijuana

Marijuana has been used for thousands of years for medical conditions, as well as for recreational purposes. The terms “marijuana” and “cannabis” are used interchangeably; however, cannabis is the more contemporary clinical designation. The use of marijuana has increased recently among US adults (18 years and older), from 10% in 2002 to 13% in 2014. The rise in marijuana use coincides with a declining perception of risk linked with its use, and its use is more prevalent in states with ...
The Rx Consultant

Hormonal Contraceptives

There are 61 million women of childbearing age (15–44) in the US. About 43 million of these women are at risk of unintended pregnancy; they are sexually active and do not want to become pregnant. About two-thirds of them use a contraceptive method correctly and consistently. Oral contraceptives have been in use for over 50 years and are one of the most popular contraceptives; this method is used by 26% of contraceptive users. Most oral contraceptives contain 2 hormones, an estrogen and a pro...
The Rx Consultant

Chronic Insomnia

Insomnia is one of the most common medical complaints, generating over 5 million office visits per year in the US alone. Symptoms of insomnia occur in one-third to one-half of adults in the US, and are more prevalent among women and older adults. In patients with coexisting psychiatric illnesses, the incidence approaches 50% to 75%. About 1 in 10 adults has chronic insomnia – symptoms that occur at least 3 times per week for at least 3 months. Among patients with chronic insomnia, up to one-...
The Rx Consultant

Pharmacy Law: Determining the Legitimacy of Opioid Prescriptions

The pharmacists at XYZ Pharmacy are concerned. The pharmacy is in close proximity to a pain management clinic and patients from this clinic regularly present the pharmacists with prescriptions for MS Contin®, oxycodone, methadone, and other opioids in quantities as large as 1,000 tablets for a 1-month supply. Those prescriptions are usually accompanied with prescriptions for fentanyl oral lozenges. A few other physicians in the area also write prescriptions for large quantities of opioids and...
The Rx Consultant

Antibiotic Stewardship: Improving Use In The Community

Antibiotic stewardship is the effort to improve antibiotic prescribing so that antibiotics are used correctly - and only when needed. It includes monitoring antibiotic prescribing; avoiding unnecessary use; minimizing underuse due to missed or delayed diagnoses; and, when an antibiotic is needed, ensuring selection of the appropriate drug, dose, route of administration, and duration of therapy. The goal of antibiotic stewardship is to treat infections effectively, while minimizing unintended c...
The Rx Consultant

Smoking Cessation For the Busy Clinician

More than 50 years after the landmark 1964 Surgeon General’s Report on the health consequences of smoking, an estimated 15% of adult Americans still smoke. Smoking remains the leading cause of preventable death in the United States – accounting for 480,000 deaths per year (1 of every 5). People who quit smoking greatly reduce their risk for tobacco-related diseases, including cancer, heart disease, and lung disease, while also increasing life expectancy and improving quality of life. Each ...
The Rx Consultant

Pharmacy Law: Regulatory Developments Affecting Pharmacy Practice

The past few years have seen a number of legislative and regulatory changes at the federal level; both with the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA). This article will address key changes impacting pharmacy practice in the areas of compounding, drug supply chain security, biosimilars, and the regulation of controlled substances in order to prevent diversion and abuse. The passage of the Drug Quality and Security Act of 2013 (DQSA) updates the Fede...
The Rx Consultant

Osteoarthritis Management

Osteoarthritis (OA) – also called degenerative joint disease – is the most common chronic joint condition, affecting about 27 million Americans. The resulting pain, stiffness, and swelling can affect mobility, productivity, and quality of life. While no treatment has been shown to slow the progression of joint damage, a combination of non-drug interventions and drug therapy can be used to manage symptoms and improve mobility. Resistance exercise, weight loss, and psychosocial interventi...
The Rx Consultant

Fluoroquinolones Warnings & Side Effects - What You Need to Know

This issue reviews uncommon but serious side effects of systemic fluoroquinolones. Dosing considerations, use in children and during pregnancy, and potential drug interactions are also discussed. Fluoroquinolones are broad-spectrum antibiotics that have been used to treat infections of varying types and severity since the 1980s. They are well-tolerated by most patients; however, a growing body of evidence has linked fluoroquinolone use to rare but disabling, and potentially permanent, side ...
The Rx Consultant

Depression: More Reasons & Options for Recovery

Depression (major depressive disorder, or MDD) was the leading cause of disability worldwide in 2017. In 2015, 7-10% of adults and 10-12% of adolescents in the US suffered from MDD. Alarmingly, suicide completion rates in the US increased 24% from 1999 to 2014.5 In 2015, suicide was the second leading cause of death in 15-34 year olds and the third leading cause of death in 10-14 year olds. Depression is also a known contributor to the illness and death associated with chronic pain and disease...
The Rx Consultant

Medication Adherence: A Critical Component of Healthcare

This issue will bring you up to date on the impact of nonadherence on chronic conditions and strategies for increasing compliance. Key Takeaways: • Medication nonadherence contributes to poor clinical outcomes (including higher hospitalization and death rates) and increases healthcare costs. • Risk factors/red flags for medication non-adherence include depression, cognitive impairment, missed office visits, poor patient/provider relationship, and lack of response to medication. • S...
The Rx Consultant

A Breath of Fresh Air: 2017 Global Initiative for Asthma (GINA) Guidelines

The purpose of this course is to discuss the 2017 Global Initiative for Asthma (GINA) Guidelines for Management and Prevention of Asthma. Many institutions follow the National Heart, Lung, and Blood Institute (NHLBI) guidelines for the treatment of asthma, however these guidelines have not been updated since 2007. We will be discussing the evidence which has since come out leading to recommendations included in the 2017 GINA guidelines. This includes a discussion of the diagnosis, treatment, a...
MCPHS University

The Challenges of Invasive Fungal Infections in Community Hospitals: A CME Guidebook to Improve Therapy and Clinical Outcomes

This interactive digital guidebook addresses the unique challenges of the community hospital to aid community practitioners, emergency-department physicians, critical-care physicians, hematologists, oncologists, and transplant surgeons in the treatment of patients with invasive fungal infections (IFIs), particularly in immunocompromised or immunosuppressed patients. Chapter topics include the epidemiology and burden of IFIs, ensuring a timely and accurate diagnosis, and the selection of approp...
ACHL

Abuse Deterrent Formulations of Opiods

The opioid epidemic is an ongoing issue in the United States and has recently been declared a national emergency by the government. While current efforts to reduce levels of opioid abuse are showing some effect, it is a slow process due to a multitude of factors that lead to an increase in the number of people who become addicted to opioids and who furthermore, suffer from an overdose. There are several abuse deterrent formulations that have been released in the last few years with different m...
MCPHS University

Online CE/CME - New Drug Update April 2018: Parts 1 & 2

Earn 10 hours of ACPE, ANCC or AMA Category 2 credit, at the location of your choosing. At the conclusion of this session, the participant will be able to: 1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts. 2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications. 3. Describe their adverse effects and drug interactio...
University Learning Systems

New Drugs 2017

In 2017, 46 new medicines were approved by the FDA – the highest number of approvals in 21 years. Scott Gottlieb, who was sworn in as FDA Commissioner in May 2017, has made use of policy changes put into effect during recent years to accelerate the approval process. This issue of The Rx Consultant focuses on new drugs that may be important additions (including a number of “firsts”) in their therapeutic areas: venous thromboembolism prophylaxis, atopic dermatitis, hepatitis C infectio...
The Rx Consultant

Online CE - Central Nervous System

Overview of the Fundamentals of Pharmacotherapy for Disorders of the Central Nervous System At the conclusion of this session, the participant will be able to: Describe the fundamentals of neurotransmission List the sites of action of drugs that are used for CNS disorders List and describe the most common characteristics of neurotransmitters associated with the CNS List the drugs most commonly prescribed for the disorders discussed Compare and contrast the relative efficacy of drug...
University Learning Systems

Online CE - Dietary Supplements

Dietary Supplements: What the NIH and Other Experts Have to Say At the conclusion of this session, the participant will be able to: Describe consumer trends in use of dietary supplements. Discuss top dietary supplements in the U.S. including the evidence-basis for their use. Describe problems with herb and dietary supplement products and strategies to assist patients in the safe use of these products. Identify quality sources of evidence-based information about dietary supplements an...
University Learning Systems

Online CE - The Opioid Crisis

The Opioid Crisis: Safe Prescribing-Balancing the Benefits and Risks for Patients with Acute and Chronic Pain At the conclusion of this session, the participant will be able to: Describe the current data on the use and abuse of opioids in the US. Assess patients accurately with pain for consideration of an opioid trial. Establish realistic goals for pain management and restoration of function. Initiate and titrate opioid treatment (IR and ER/LA) safely and judiciously, maximizing ef...
University Learning Systems

Online CE - Hepatitis C

TEEMwork Makes the Dream Work: An Interdisciplinary Approach to Best Patient Care Practices for Hepatitis C At the conclusion of this session, the participant will be able to: Review the pathophysiology and complications of Hepatitis C Virus (HCV). Identify patients who are appropriate for treatment of HCV. Discuss current guidelines and recommendations for treatment of HCV in treatment naïve, compensated patients and in experienced, decompensated patients. Summarize common barriers...
University Learning Systems

HIV Infection: An Update on Antiretroviral Therapy – Florida Board-Approved Edition

Florida Licensees: This issue, together with the Supplement (pages 13 - 19) meets the requirement of the Florida Board of Pharmacy for a CE course on HIV/AIDS. Thirty seven years after the first case of acquired immunodeficiency syndrome (AIDS) was reported, 36.7 million people world-wide are living with HIV. About 1.8 million new HIV infections and 1 million AIDS-related deaths were reported in 2016. However, there has been significant progress in battling the disease over the last 20 year...
The Rx Consultant

Opioid Prescriptions: Balancing Misuse or Abuse With Pain Control

This CE activity meets the Florida Board of Pharmacy requirement for a Board-approved 2-hour continuing education course on the Validation of Prescriptions for Controlled Substances. It also meets other state board requirements for a continuing education course on patient safety. The appropriate and safe management of pain, and concerns about opioid overuse, abuse and overdose, have been making headlines for the past 20 years. Historically, opioids have been used for chronic non-cancer pain...
The Rx Consultant

Immunization Update: A Focus on Medical Indications for Vaccines in Adults

The Healthy People 2020 report, published by the US Department of Health and Human Services, includes targets for reducing vaccine-preventable disease rates and increasing vaccination rates in all age groups. According to the report, for each birth cohort (group of individuals born in the same year), immunization with the routine childhood vaccination schedule prevents 14 million cases of disease and reduces direct healthcare costs by $9.9 billion. Vaccines are one of the most cost-effective c...
The Rx Consultant

Diabetes Update

The American Diabetes Association (ADA) updates their practice guidelines every year, incorporating new data that can have a significant impact on patient health, care, and outcomes. Each January for the past 26 years, the ADA has published these guidelines as the Standards of Medical Care in Diabetes, referred to simply as the “Standards of Care.” This publication is the go-to reference guide for many healthcare professionals who care for people with diabetes. It provides practitioners, p...
The Rx Consultant

Hypertension Update 2018

This issue will bring you up to date on the recent guidelines for the management of hypertension in adults. Key Takeaways: • Two guidelines, two definitions of hypertension: The 2017 ACC/AHA guideline defines stage 1 hypertension as a BP of 130/80 mmHg or above. In contrast, the hypertension guideline from the 8th Joint National Committee (JNC 8) defines hypertension as BP of 140/90 mmHg or above - an ongoing controversy. • Think preventive: ACC/AHA recommends lifestyle changes for p...
The Rx Consultant

Online CE - What’s New with Lipid Management: Managing Statin Intolerance, Consensus Recommendations, New Evidence, and PCSK9 Inhibitors

At the conclusion of this session, the participant will be able to: 1. Review medications and lifestyle modifications that are recommended for the treatment of dyslipidemia. 2. Identify the patient populations that benefit from statin therapy according to consensus guidelines. 3. Discuss recommendations from the US Preventative Services Task Force for statin therapy in primary prevention. 4. Define the role in of nonstatin therapy in the treatment of dyslipidemia. 5. Compare and contra...
University Learning Systems

Online CE - What’s New with Hypertension: How Low to Go, New Evidence, Consensus Recommendations, and Treating Resistant Hypertension

At the conclusion of this session, the participant will be able to: Review medications and lifestyle modifications that are recommended for the treatment of hypertension. Compare and contrast guidelines and consensus recommendations for the treatment of patients with hypertension. Identify patient specific blood pressure goals for patients with hypertension. Interpret findings from the SPRINT trial and identify strengths and weaknesses of these data when applies to determining a patient-...
University Learning Systems

Online CE - Advances in the Management of Diabetes

At the conclusion of this session, the participant will be able to: Review recent updates to the standards of care recommended by the American Diabetes Association. Evaluate the advantages, disadvantages, and place in therapy for recently approved diabetes medications. Describe recent cardiovascular outcome trials for new diabetes medications and their implications for patient care. Identify new insulin delivery devices and glucose monitoring devices and Determine their utility in patie...
University Learning Systems

Management of Chronic Pain for the Community Pharmacist

As we are amidst the opioid epidemic, it is imperative that pharmacists are aware of updated policies, guidelines, and best practices surrounding pain management with opioids. This CE will discuss updates to Massachusetts Law and CDC's guidelines on chronic pain management (released 03/2016). Recommendations from the updated guidelines will be applied to a community pharmacy setting and provide pharmacists with best practices in order to improve safety and efficiency when dispensing opioid med...
MCPHS University

Therapeutics in Glaucoma

Glaucoma is a chronic and progressive pathology. While treatment approaches are inclusive of laser therapy and surgical interventions, common initial strategies involve implementing topical medication therapy. Pharmacists are at the forefront of this latter therapeutic approach. Epidemiologically, diagnoses of glaucoma are widespread. Tham et al (2014) have reported that more than 60 million individuals (40-80 years of age) are impacted by glaucoma, based upon 2013 data. This number is expecte...
MCPHS University

Dispensing Emergency Contraception Through a Standing Order - 2017 Update

Through Massachusetts General Law 94c Section 19A pharmacists are able to dispense emergency contraception (levonorgestrel and ulipristal acetate) through a standing order signed by an active, registered, physician. This presentation has been approved by the Department of Public Health (DPH) to meet the requirements for special training for emergency contraception. Upon completing this continuing education, registered pharmacists in the state of Massachusetts will meet all necessary requirem...
MCPHS University

Antiretroviral Drug Interactions: What Every Pharmacist Should Now

The number of patients diagnosed with human immunodeficiency virus (HIV) has been slowly declining over the past 10 years. But with current antiretroviral therapy (ART) options, patients with HIV are living much longer than they ever have before, approaching the life expectancy of a patient without HIV. ART is life-saving for HIV patients, but they are required to be on these medications indefinitely, and the majority of these medications have significant adverse effects and drug interactions....
MCPHS University

The Impact of New Anti-Diabetic Agents on Cardiovascular Outcomes

Currently in the field of pharmacy, cardiovascular outcomes trial results are being posted online and featured on the news. Diabetes guidelines have not been updated to reflect this data and so it is up to the pharmacist to review these clinical trials and propose what the best practice would be for their patients. Clinicians are asking about the importance of cardiovascular outcomes data with the new anti-diabetic agents and it is our responsibility to educate them about the newest data avail...
MCPHS University

Improving Metastatic Colorectal Cancer (mCRC) Care in Community Cancer Centers

The clinical management of patients with metastatic colorectal cancer (mCRC) continues to evolve as advances in research lead to new approaches in molecular biomarker testing and the application of treatment plans that are tailored for each patient. The goal of this program is to educate and enable members of the cancer care team to apply the latest guidelines and evidence when managing patients with mCRC.
American Academy of CME

comMIt (comprehensive motivational interviewing) for health care professionals

comMIt (comprehensive motivational interviewing training) for health care professionals is an e-learning program accredited for 8 hours of approved continuing education credit for dietitians, nurses, pharmacists, physicians and social workers. The learner has three months to complete this highly interactive program and receive CE credit. Learners may stop at any point in the program and then return to it where they left off. Learners may also review each module completed as often as they wou...
Berger Consulting, LLC

Contemporary Compounding Intensive CE

Class Overview Non-sterile compounded medications often play an extremely important role in the quality of patient care and prescribers have become increasingly aware of the benefits that customized medications offer. The pharmacist and pharmacy technician must have a strong foundation on how to prepare these products. Technology has provided the equipment and techniques necessary to compound effectively and accurately. To prepare participants to meet the needs of patients, we have designe...
Western University of Health Sciences, College of Pharmacy

Dispensing Opioids: Decisions to Improve Medication Safety

At the time of dispensing, health professionals are exposed to patients who are struggling with uncontrolled asthma or poorly controlled COPD. Caregivers are also seeking better ways to management this chronic condition. The online module entitled Optimizing Patient Use of Inhalers and Other Respiratory Devices will equip learners with a practical understanding of devices to deliver drug to the lungs. Video demonstrations help learners become familiar with how to identify poor inhaler techniq...
University of Maryland School of Pharmacy: CIPS Knowledge Enterprise

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.